Weve written extensively about the prevalence of obesity and its consequences ( more here ), so Ill keep it brief
One in three women undergoing axillary lymph node dissection and radiotherapy will develop this incurable and disabling disease ( As far back as 1957 studies have shown that obesity can increase the risk of secondary lymphedema ( Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were originally brought to market as treatments for diabetes, and were noted to induce weight loss ( Although weight loss has been reported to be beneficial in the treatment of lymphedema, no studies to date have examined the use of GLP-1RAs for the treatment of secondary lymphedema
Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress
Typical Weekly Pattern During This Phase Weight loss: 0.5-1 pound weekly on average, with occasional plateau weeks Appetite: Remains suppressed but slightly less dramatically than weeks 13-24 Energy: Stable, though some people report slight decrease from peak energy in weeks 16-24 Side effects: Minimal
At Midi Health, were fielding questions every day from women who want to know which peptides are backed by science, which are overhyped, and whether they actually need them
Market trends indicate a massive shift toward long-acting injectables and a growing interest in oral formulations to improve patient adherence Yahoo